Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT IRONWOOD PHARMACEUTICALS, INC.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
Listen to this Section


$3.36
-0.0450 ( -1.32% ) 624.0K

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Clinical Trial Pipeline Stages


Drug Name Stage
Linzess® (linaclotide)DetailsConstipation Approved
Linzess® (linaclotide)DetailsIrritable bowel syndrome, Inflammatory bowel disease, Bowel disorder Approved
Apraglutide (agonist of the GLP-2 receptor)DetailsShort bowel syndrome Phase 3
Apraglutide (agonist of the GLP-2 receptor)DetailsAcute graft-versus host disease Phase 2
IW-3300DetailsEndometriosis, Visceral pain, Interstitial cystitis/bladder pain syndrome Phase 2
Apraglutide (agonist of the GLP-2 receptor)DetailsShort bowel syndrome with colon-in-continuity , Short bowel syndrome Phase 2
CNP-104DetailsPrimary biliary cholangitis, Liver disease, Autoimmune disease Phase 2a
LinaclotideDetailsIrritable bowel syndrome, Inflammatory bowel disease, Bowel disorder, Constipation Failed

Market Data


Open $3.36
Previous Close $3.40
Volume 624.0K
Market Cap $533.35M
Day Range $3.33 - $3.50
52 Week Range $0.56 - $5.78
Shares Outstanding 164.61M
Change % -1.32%
Net Change ▼ -0.0450
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Year2010
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,798,351.00

Date Type Amount Purchased Purchaser
2024-02-14 Sale -9846.00 Davis Andrew
2024-02-14 Sale -65312.00 Emany Sravan Kumar
2024-02-14 Sale -177164.00 MCCOURT Thomas A
2024-02-12 Sale -41332.00 Emany Sravan Kumar
2024-01-19 Sale -79981.00 John Minardo
2024-01-19 Sale -85000.00 Emany Sravan Kumar
2024-01-19 Sale -57971.00 Shetzline Michael
2024-01-19 Sale -249617.00 MCCOURT Thomas A
2023-12-19 Sale -1347.00 DENNER ALEXANDER J
2023-12-19 Sale -1572.00 Moukheibir Catherine

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 83 Nov 10, 2025
8-k 8K-related 14 Nov 10, 2025
8-k 8K-related 12 Oct 10, 2025
4 Insider transactions 1 Sep 17, 2025
8-k 8K-related 12 Sep 03, 2025
4 Insider transactions 2 Aug 13, 2025
4 Insider transactions 1 Aug 13, 2025
4 Insider transactions 1 Aug 13, 2025
4 Insider transactions 1 Aug 13, 2025
10-q Quarterly Reports 81 Aug 11, 2025

Latest News


× Before browsing our site, please accept our cookies policy